[1] Liu Q, Jia WL, Zhang MM, Liu C, Zhang YM. Clinical progress of frontotemporal lobe degeneration[J]. Zhongguo Yi Kan, 2020, 55:840-843.[刘琪, 贾伟丽, 张美美, 刘畅, 张玉梅. 额颞叶变性的临床研究进展[J]. 中国医刊, 2020, 55:840-843.] [2] Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, Radke A, Karydas A, Kornak J, Sias AC, Rabinovici GD, Gorno-Tempini ML, Boxer AL, De May M, Rankin KP, Sturm VE, Lee SE, Matthews BR, Kao AW, Vossel KA, Tartaglia MC, Miller ZA, Seo SW, Sidhu M, Gaus SE, Nana AL, Vargas JNS, Hwang JL, Ossenkoppele R, Brown AB, Huang EJ, Coppola G, Rosen HJ, Geschwind D, Trojanowski JQ, Grinberg LT, Kramer JH, Miller BL, Seeley WW. Clinicopathological correlations in behavioural variant frontotemporal dementia[J]. Brain, 2017, 140:3329-3345. [3] Mesulam MM, Weintraub S. Is it time to revisit the classification guidelines for primary progressive aphasia[J]? Neurology, 2014, 82:1108-1109. [4] Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF. Frontotemporal lobar degeneration:a consensus on clinical diagnostic criteria[J]. Neurology, 1998, 51:1546-1554. [5] Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia[J]. Brain, 2011, 134(Pt 9):2456-2477. [6] Tonacci A, Billeci L. Olfactory testing in frontotemporal dementia:a literature review[J]. Am J Alzheimers Dis Other Demen, 2018, 33:342-352. [7] Coyle-Gilchrist IT, Dick KM, Patterson K, Vázquez Rodríquez P, Wehmann E, Wilcox A, Lansdall CJ, Dawson KE, Wiggins J, Mead S, Brayne C, Rowe JB. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes[J]. Neurology, 2016, 86:1736-1743. [8] Younes K, Miller BL. Frontotemporal dementia:neuropathology, genetics, neuroimaging, and treatments[J]. Psychiatr Clin North Am, 2020, 43:331-344. [9] Peng DT. New international guidelines and consensus in the field of cognitive impairment[J]. A Er Ci Hai Mo Bing Ji Xiang Guan Bing, 2020, 3:174-176.[彭丹涛. 国际新近认知障碍领域指南及共识[J]. 阿尔茨海默病及相关病, 2020, 3:174-176.] [10] Hernandez I, Fernandez MV, Tarraga L, Boada M, Ruiz A. Frontotemporal Lobar Degeneration (FTLD):review and update for clinical neurologists[J]. Curr Alzheimer Res, 2018, 15:511-530. [11] Tu S, Spiers HJ, Hodges JR, Piguet O, Hornberger M. Egocentric versus allocentric spatial memory in behavioral variant frontotemporal dementia and Alzheimer's disease[J]. J Alzheimers Dis, 2017, 59:883-892. [12] Cotelli M, Manenti R, Brambilla M, Gobbi E, Ferrari C, Binetti G, Cappa SF. Cognitive telerehabilitation in mild cognitive impairment, Alzheimer's disease and frontotemporal dementia:a systematic review[J]. J Telemed Telecare, 2019, 25:67-79. [13] Li P, Zhou YY, Tian ZY, Lu D, Zhang HH, Liu S. Comparative analysis of cognitive function and neuropsychiatric behavior between Alzheimer's disease and frontotemporal dementia patients[J]. Zhonghua Shen Jing Ke Za Zhi, 2014, 47:610-616.[李攀, 周玉颖, 田志岩, 陆达, 张惠红, 刘帅. 额颞叶痴呆和阿尔茨海默病患者认知功能及神经精神行为比较[J]. 中华神经科杂志, 2014, 47:610-616.] [14] Chen H, Ji DX, Yin JZ. Diagnostic value of olfactory function evaluation in different types of dementia[J]. Guo Ji Yi Xue Fang She Xue Za Zhi, 2019, 42:409-412.[陈红, 纪东旭, 尹建忠. 嗅觉功能评价在不同痴呆类型诊断中的价值[J]. 国际医学放射学杂志, 2019, 42:409-412.] [15] Jobin B, Zahal R, Bussières EL, Frasnelli J, Boller B. Olfactory identification in subjective cognitive decline:a meta-analysis[J]. J Alzheimers Dis, 2021, 79:1497-1507. [16] Alves J, Petrosyan A, Magalhães R. Olfactory dysfunction in dementia[J]. World J Clin Cases, 2014, 2:661-667. [17] Silva MME, Viveiros CP, Kotsifas NJE, Duarte A, Dib E, Mercer PBS, Pessoa RR, Witt MCZ. Olfactory impairment in frontotemporal dementia:a systematic review and meta-analysis[J]. Dement Neuropsychol, 2019, 13:154-161. [18] Carnemolla SE, Hsieh JW, Sipione R, Landis BN, Kumfor F, Piguet O, Manuel AL. Olfactory dysfunction in frontotemporal dementia and psychiatric disorders:a systematic review[J]. Neurosci Biobehav Rev, 2020, 118:588-611. [19] Omar R, Mahoney CJ, Buckley AH, Warren JD. Flavour identification in frontotemporal lobar degeneration[J]. J Neurol Neurosurg Psychiatry, 2013, 84:88-93. [20] Piwnica-Worms KE, Omar R, Hailstone JC, Warren JD. Flavour processing in semantic dementia[J]. Cortex, 2010, 46:761-768. [21] Wang P, Zhang HH, Wang Y, Zhang M, Chen Y, Xu XL, Zhou YY. Characteristics of cognitive-neuropsychiatric behavioural features and 18F-FDG PET images in progressive supranuclear palsy and behavioral variant frontotemporal dementia[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2020, 20:813-820.[王盼, 张惠红, 王艳, 张淼, 陈嫄, 徐小林, 周玉颖. 进行性核上性麻痹与行为异常型额颞叶痴呆患者认知-精神行为及18F-FDG PET显像特征研究[J]. 中国现代神经疾病杂志, 2020, 20:813-820.] [22] Thijssen EH, La Joie R, Wolf A, Strom A, Wang P, Iaccarino L, Bourakova V, Cobigo Y, Heuer H, Spina S, VandeVrede L, Chai X, Proctor NK, Airey DC, Shcherbinin S, Duggan Evans C, Sims JR, Zetterberg H, Blennow K, Karydas AM, Teunissen CE, Kramer JH, Grinberg LT, Seeley WW, Rosen H, Boeve BF, Miller BL, Rabinovici GD, Dage JL, Rojas JC, Boxer AL; Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators. Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration[J]. Nat Med, 2020, 26:387-397. [23] Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, Herholz K, Hutton BF, Jack CR Jr, Lammertsma AA, Landau SM, Minoshima S, Nobili F, Nordberg A, Ossenkoppele R, Oyen WJG, Perani D, Rabinovici GD, Scheltens P, Villemagne VL, Zetterberg H, Drzezga A. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias[J]. Lancet Neurol, 2020, 19:951-962. |